Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report

Ohkubo, M; Fukuda, K; Chiba, S; Homma, M

Homma, M (通讯作者),Univ Tsukuba Hosp, Dept Pharm, Ibaraki, Japan.;Homma, M (通讯作者),Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Pharmaceut Sci, Ibaraki, Japan.

JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023; 9 (1):

Abstract

BackgroundNucleoside analogues (NAs) such as entecavir are required for at least 12 months when patients with resolved hepatitis B virus (HBV) infecti......

Full Text Link